In the past week, ONC stock has gone down by 0.00%, with a monthly gain of 1.39% and a quarterly surge of 47.78%. The volatility ratio for the week is 2.67%, and the volatility levels for the last 30 days are 3.70% for BeiGene Ltd. ADR The simple moving average for the last 20 days is 2.63% for ONC stock, with a simple moving average of 30.45% for the last 200 days.
Is It Worth Investing in BeiGene Ltd. ADR (NASDAQ: ONC) Right Now?
Company’s 36-month beta value is 0.53.Analysts have differing opinions on the stock, with 15 analysts rating it as a “buy,” 7 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for ONC is 97.64M, and currently, short sellers hold a 1.68% ratio of that floaft. The average trading volume of ONC on March 28, 2025 was 432.00K shares.
ONC) stock’s latest price update
BeiGene Ltd. ADR (NASDAQ: ONC) has seen a rise in its stock price by 4.65 in relation to its previous close of 250.92. benzinga.com reported 2025-03-04 that On Tuesday, BeiGene Ltd ONC announced FDA approval for Tevimbra (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the first-line treatment of adults with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) whose tumors express PD-L1 (≥1).
Analysts’ Opinion of ONC
Many brokerage firms have already submitted their reports for ONC stocks, with BofA Securities repeating the rating for ONC by listing it as a “Buy.” The predicted price for ONC in the upcoming period, according to BofA Securities is $320 based on the research report published on March 03, 2025 of the current year 2025.
Morgan Stanley, on the other hand, stated in their research note that they expect to see ONC reach a price target of $300. The rating they have provided for ONC stocks is “Overweight” according to the report published on December 03rd, 2024.
JMP Securities gave a rating of “Mkt Outperform” to ONC, setting the target price at $288 in the report published on September 18th of the previous year.
ONC Trading at 9.17% from the 50-Day Moving Average
After a stumble in the market that brought ONC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.78% of loss for the given period.
Volatility was left at 3.70%, however, over the last 30 days, the volatility rate increased by 2.67%, as shares sank -5.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +30.65% upper at present.
During the last 5 trading sessions, ONC remain unchanged, which changed the moving average for the period of 200-days by +67.95% in comparison to the 20-day moving average, which settled at $255.87. In addition, BeiGene Ltd. ADR saw 42.17% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ONC starting from Wang Xiaodong, who sale 41,760 shares at the price of $261.28 back on Mar 18 ’25. After this action, Wang Xiaodong now owns 0 shares of BeiGene Ltd. ADR, valued at $10,911,252 using the latest closing price.
OYLER JOHN, the Chief Executive Officer of BeiGene Ltd. ADR, sale 41,210 shares at $242.67 during a trade that took place back on Mar 10 ’25, which means that OYLER JOHN is holding 0 shares at $10,000,483 based on the most recent closing price.
Stock Fundamentals for ONC
Current profitability levels for the company are sitting at:
- -0.15 for the present operating margin
- 0.84 for the gross margin
The net margin for BeiGene Ltd. ADR stands at -0.17. The total capital return value is set at -0.15. Equity return is now at value -18.77, with -10.99 for asset returns.
Based on BeiGene Ltd. ADR (ONC), the company’s capital structure generated 0.24 points at debt to capital in total, while cash flow to debt ratio is standing at -0.13.
Currently, EBITDA for the company is -396.44 million with net debt to EBITDA at 3.9. When we switch over and look at the enterprise to sales, we see a ratio of 7.24. The receivables turnover for the company is 5.37for trailing twelve months and the total asset turnover is 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.
Conclusion
In a nutshell, BeiGene Ltd. ADR (ONC) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
